Peripheral Angioplasty Market

• Growing number of elderly people is driving the market growth

Market CAGR for Peripheral Angioplasty is being driven by the Growing Number of Elderly People. Narrowed arteries in peripheral arterial disease (PAD) limit blood flow to the limbs. PAD is a common circulatory condition. The arteries that bring blood from the heart to the brain, arms, kidneys, and stomach are occasionally affected by PAD, but primarily the arteries in the legs are affected. It is brought on by fat deposits (plaques) in the artery walls, which lower blood flow to the head, limbs, and organs.

Additionally, peripheral angioplasty treatments are in high demand to open blocked or narrowed arteries and restore blood flow because of the rising prevalence of peripheral artery disease (PAD), which includes atherosclerosis and is more common in the elderly population. Peripheral angioplasty operations are becoming more successful and effective because to ongoing improvements in angioplasty techniques, including the creation of drug-coated balloons, atherectomy devices, and enhanced stent technology. Peripheral angioplasty has become more popular since patients and medical professionals find that minimally invasive procedures have fewer side effects, quicker recovery periods, and fewer hospital stays than standard surgeries.

The prevalence of peripheral arterial disorders is higher in the aging population. Peripheral angioplasty is one intervention that is becoming more and more necessary as this demographic keeps growing.

The incidence of peripheral arterial disorders is influenced by lifestyle-related factors such obesity, diabetes, and hypertension. Peripheral angioplasty is one intervention that is necessary to treat associated arterial blockages and stenosis. Peripheral angioplasty market expansion is aided by government programs that support enhanced access to healthcare, better healthcare infrastructure, and investments in cutting-edge medical technologies. Peripheral angioplasty procedures are increasingly accessible to patients due to favorable reimbursement regulations that incentivize healthcare professionals to offer them.

Peripheral angioplasty device innovation is fueled by competition among medical device makers, which leads to the creation of more sophisticated and potent devices and more treatment alternatives for patients.

For instance, peripheral artery disease (PAD) affects over 6.5 million adults in North America who are 40 years of age and older. This information comes from the Centers for Disease Control and Prevention (CDC). Some of the main high-risk factors that lead to an increase in new PAD cases ly are smoking, coronary artery disease diabetes, high blood pressure, and cholesterol. Thus, result in driving the Peripheral Angioplasty market revenue.

The Global Peripheral Angioplasty Market Industry is poised for substantial growth, with projections indicating a market value of 4.21 USD Billion in 2024 and an anticipated increase to 9.71 USD Billion by 2035. This growth trajectory reflects a compound annual growth rate (CAGR) of 7.89% from 2025 to 2035. Factors such as rising prevalence of peripheral arterial disease, technological advancements, and increasing healthcare expenditure are expected to drive this expansion. As the industry evolves, it is likely to witness further innovations and improvements in patient care, solidifying its importance in the management of vascular health.

The expanding geriatric population is a crucial driver of the Global Peripheral Angioplasty Market Industry. As individuals age, they are more susceptible to cardiovascular diseases, including PAD, necessitating effective treatment options. The demographic shift towards an older population is prompting healthcare systems to adapt and provide specialized care for age-related conditions. This trend is expected to fuel the demand for angioplasty procedures, as older adults often require interventions to manage their vascular health. The market's growth trajectory is likely to be influenced by this demographic change, with increasing numbers of elderly patients seeking angioplasty as a viable treatment option.

The rise in global healthcare expenditure is a significant factor propelling the Global Peripheral Angioplasty Market Industry. Governments and private sectors are investing more in healthcare infrastructure, leading to improved access to advanced medical technologies and treatments. This trend is particularly evident in developing regions, where increased funding is directed towards cardiovascular care. As healthcare systems evolve, the demand for effective interventions like angioplasty is likely to grow. This increased investment is expected to support the market's expansion, with projections indicating a market value of 9.71 USD Billion by 2035, reflecting the ongoing commitment to enhancing patient care.

Supportive regulatory frameworks and favorable reimbursement policies play a pivotal role in shaping the Global Peripheral Angioplasty Market Industry. Governments and health organizations are increasingly recognizing the importance of angioplasty in managing vascular diseases, leading to the establishment of guidelines that promote its use. Additionally, improved reimbursement policies facilitate patient access to these procedures, encouraging healthcare providers to offer angioplasty as a standard treatment option. This regulatory environment is likely to enhance market growth, as it fosters confidence among patients and providers alike, ultimately contributing to the overall expansion of the industry.

The increasing incidence of peripheral arterial disease (PAD) is a primary driver for the Global Peripheral Angioplasty Market Industry. As populations age, the prevalence of conditions such as diabetes and hypertension rises, contributing to vascular complications. In 2024, the market is projected to reach 4.21 USD Billion, reflecting the urgent need for effective treatment options. The growing awareness of PAD and its associated risks is prompting healthcare providers to adopt angioplasty procedures more frequently. This trend is likely to continue as educational initiatives highlight the importance of early diagnosis and intervention, ultimately driving market growth.

Innovations in angioplasty technology significantly influence the Global Peripheral Angioplasty Market Industry. The development of advanced balloon catheters, drug-eluting stents, and imaging techniques enhances procedural efficacy and patient outcomes. These advancements not only improve the safety and effectiveness of angioplasty but also expand its applications in treating complex vascular conditions. As a result, healthcare providers are increasingly adopting these technologies, contributing to market growth. The anticipated CAGR of 7.89% from 2025 to 2035 indicates a robust future for the industry, driven by continuous innovation and the introduction of next-generation devices.

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American Peripheral Angioplasty market area will dominate this market. This is because the market is driven by factors including rising rates of cardiovascular illnesses and an aging population. Additionally, the market is growing as a result of the rising number of cardiovascular disease cases in the United States. Moreover, the bulk of the significant industry participants are present in North America.

Further, the major countries studied in the market report are The US, German, France, the UK, Canada, Italy, Spain, India, Australia, South Korea, China, Japan, and Brazil.

Figure2: PERIPHERAL ANGIOPLASTY MARKET SHARE BY REGION 2023 (USD Billion)

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

Europe Peripheral Angioplasty market has the second-largest portion of the market. This is due to an increase in the aging population in the region. Further, the German Peripheral Angioplasty market had the biggest market share, and the UK Peripheral Angioplasty market was the European market with the quickest rate of growth.

The Asia-Pacific Peripheral Angioplasty Market is anticipated to expand between 2024 and 2032 at the quickest CAGR. This is due to the growing prevalence of diabetes, which raises the risk of peripheral vascular diseases. Moreover, China’s Peripheral Angioplasty market had the biggest market share, and the Indian Peripheral Angioplasty market was the Asia-Pacific region's fastest-growing market.

Leading market players are putting a lot of money on R&D to expand their product lines, which will drive the peripheral angioplasty market's expansion. Additionally, market players are engaging in a range of calculated initiatives to increase their worldwide presence, with important market developments involving the introduction of new products, contracts, M&A transactions, increased investment, and cooperation with other enterprises. To grow and endure in an increasingly cutthroat and dynamic market, Peripheral Angioplasty industry must provide reasonably priced goods.

Manufacturing locally is one of the primary business techniques used by manufacturers to cut operational costs in the  Peripheral Angioplasty industry to help customers and expand the market segment. In recent years, the Peripheral Angioplasty industry has provided some of the biggest benefits to medicine. Major players in the Peripheral Angioplasty market, including Edwards Lifesciences Corporation, B. Braun Melsungen AG, Cook Medical, Johnson & Johnson, Terumo Corporation, Medtronic, Abbott Laboratories, Boston Scientific Corporation, and others, are engaging in research and development activities in an effort to boost market demand.

Boston Scientific Corporation ("BSC") is a worldwide biomedical/biotechnology engineering company that produces medical devices for use in a variety of interventional medical disciplines, such as interventional cardiology and radiology. On June 29, 1979, Boston Scientific was established in Watertown, Massachusetts, forty-four years ago, as a holding company for Medi-Tech, Inc., a medical goods company, with the goal of positioning the latter for expansion into the field of interventional medicine. Itzhak Bentov, a Czech who immigrated to Israel and later the US, was the creator of Medi-Tech.

In January 2021, Boston declared that it will pay up to $1.2 billion to acquire Minneapolis-based Preventice Solutions, Inc. and its suite of mobile heart health solutions.

Abbott Laboratories is a worldwide medical equipment and healthcare firm. In addition to selling medical equipment, diagnostics, branded generic medications, and nutritional goods, the company was established in 1888 by Chicago physician Wallace Calvin Abbott to develop well-known drugs. In 2013, it divided into AbbVie and separated its research-based pharmaceutical division. MitraClip, Glucerna, Ensure, ZonePerfect, FreeStyle Libre, i-STAT, Similac, Pedialyte, and BinaxNOW are among the products made by Abbott. In January 2022, Abbott unveiled Lingo, a set of consumer biowearable sensors that gathers biological data to enhance diet and exercise plans.